Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: Findings from the FrEDI randomized controlled trial

Nephrology Dialysis Transplantation

Volumn 32, Issue 7, 2017, Pages 1233-1243

  Rhee, Connie M ^a   You, Amy S ^a   Parsons, Tara Koontz ^b   Tortorici, Amanda R ^a   Bross, Rachelle ^b   St Jules, David E ^c   Jing, Jennie ^a   Lee, Martin L ^d   Benner, Debbie ^e   Kovesdy, Csaba P ^f,g   Mehrotra, Rajnish ^h   Kopple, Joel D ^b,d,i   Kalantar Zadeh, Kamyar ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DAVITA INC   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF WASHINGTON   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Hemodialysis; High protein; Hyperphosphatemia; Hypoalbuminemia; Protein energy wasting

Indexed keywords

ALBUMIN; INTERLEUKIN 6; LANTHANUM CARBONATE; PHOSPHORUS; LANTHANUM;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; BONE DISEASE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN DIET; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; ADMINISTRATION AND DOSAGE; BLOOD; COMPLICATION;

BONE DISEASES; DIETARY PROTEINS; FEMALE; HUMANS; HYPOALBUMINEMIA; LANTHANUM; MALE; MIDDLE AGED; PHOSPHORUS; RENAL DIALYSIS;

EID: 85038097737     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfw323     Document Type: Article

References (34)

1. Kovesdy CP, Kalantar-Zadeh K. Accuracy and limitations of the diagnosis of malnutrition in dialysis patients. Semin Dial 2012; 25: 423-427
2. Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, National Kidney Foundation. Am J Kidney Dis 2000; 35(6 Suppl 2): S1-S140
3. Beddhu S, Kaysen GA, Yan G et al. Association of serum albumin and atherosclerosis in chronic hemodialysis patients. Am J Kidney Dis 2002; 40: 721-727
4. Lacson E, Jr, Wang W, Hakim RM et al. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access. Am J Kidney Dis 2009; 53: 79-90
5. Shinaberger CS, Kilpatrick RD, Regidor DL et al. Longitudinal associations between dietary protein intake and survival in hemodialysis patients. Am J Kidney Dis 2006; 48: 37-49
6. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004; 15: 2208-2218
7. Fouque D, Roth H, Pelletier S et al. Control ofmineralmetabolism and bone disease in haemodialysis patients: which optimal targets? Nephrol Dial Transplant 2013; 28: 360-367
8. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780
9. Ketteler M, Floege J. Calcification and the usual suspect phosphate: still guilty but there are other guys behind the scenes. Nephrol Dial Transplant 2006; 21: 33-35
10. Ketteler M, Westenfeld R, Schlieper G et al. Pathogenesis of vascular calcification in dialysis patients. Clin Exp Nephrol 2005; 9: 265-270
11. Schlieper G, Brandenburg V, Djuric Z et al. Risk factors for cardiovascular calcifications in non-diabetic Caucasian haemodialysis patients. Kidney Blood Press Res 2009; 32: 161-168
12. Fouque D, Horne R, Cozzolino M et al. Balancing nutrition and serum phosphorus inmaintenance dialysis. Am J Kidney Dis 2014; 64: 143-150
13. Kalantar-Zadeh K, Ikizler TA. Let them eat during dialysis: an overlooked opportunity to improve outcomes in maintenance hemodialysis patients. J Ren Nutr 2013; 23: 157-163
14. Burrowes JD, Larive B, Cockram DB et al. Effects of dietary intake, appetite, and eating habits on dialysis and non-dialysis treatment days in hemodialysis patients: cross-sectional results from the HEMO study. J Ren Nutr 2003; 13: 191-198
15. Kalantar-Zadeh K, Cano NJ, Budde K et al. Diets and enteral supplements for improving outcomes in chronic kidney disease. Nat Rev Nephrol 2011; 7: 369-384
16. Kalantar-Zadeh K, Tortorici AR, Chen JL et al. Dietary restrictions in dialysis patients: is there anything left to eat? Semin Dial 2015; 28: 159-168
17. Daugirdas JT, Finn WF, Emmett M et al. The phosphate binder equivalent dose. Semin Dial 2011; 24: 41-49
18. SullivanC, Sayre SS, Leon JB et al. Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial. JAMA 2009; 301: 629-635
19. Kalantar-Zadeh K, Kilpatrick RD, Kuwae N et al. Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant 2005; 20: 1880-1888
20. Kopple JD, Cheung AK, Christiansen JS et al. OPPORTUNITY: a randomized clinical trial of growth hormone on outcome in hemodialysis patients. Clin J AmSoc Nephrol 2008; 3: 1741-1751
21. Lacson E, Jr, Ikizler TA, Lazarus JM et al. Potential impact of nutritional intervention on end-stage renal disease hospitalization, death, and treatment costs. J RenNutr 2007; 17: 363-371
22. Nussbaum SR, Zahradnik RJ, Lavigne JR et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33: 1364-1367
23. Stel VS, Zoccali C, Dekker FW et al. The randomized controlled trial. Nephron Clin Pract 2009; 113: c337-c342
24. OwenWF, Jr, Lew NL, Liu Y et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl JMed 1993; 329: 1001-1006
25. Shinaberger CS, Greenland S, Kopple JD et al. Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr 2008; 88: 1511-1518
26. Pupim LB, Majchrzak KM, Flakoll PJ et al. Intradialytic oral nutrition improves protein homeostasis in chronic hemodialysis patients with deranged nutritional status. J Am Soc Nephrol 2006; 17: 3149-3157
27. Caglar K, Fedje L, Dimmitt R et al. Therapeutic effects of oral nutritional supplementation during hemodialysis. Kidney Int 2002; 62: 1054-1059
28. Rattanasompattikul M, Molnar MZ, Lee ML et al. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebocontrolled trial. J Cachexia SarcopeniaMuscle 2013; 4: 247-257
29. Aime S, Canavese C, Stratta P. Advisory about gadolinium calls for caution in the treatment of uremic patients with lanthanum carbonate. Kidney Int 2007; 72: 1162-1163
30. Slatopolsky E, Liapis H, Finch J. Progressive accumulation of lanthanum in the liver of normal and uremic rats. Kidney Int 2005; 68: 2809-2813
31. Kovesdy CP, Regidor DL, Mehrotra R et al. Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2007; 2: 999-1007
32. Ling PR, Smith RJ, Kie S et al. Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats. Am J Physiol Regul Integr Comp Physiol 2004; 287: R801-R808
33. Wizemann V. Regular dialysis treatment in Germany: the role of non-profit organisations. J Nephrol 2000; 13(Suppl 3): S16-S19
34. Leavey SF, Strawderman RL, Young EWet al. Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int 2000; 58: 2119-2128